Objectives. This study sought to evaluate a biochemical approach to the early noninvasive assessment of reperfusion.
Intravenous thrombolytic therapy for acute myocardial infarction (MI) yields maximal benefit if there is early and sustained restoration of Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow (1) in the infarct-related artery (IRA) (2) . However, failure of complete reperfusion by 90 min after thrombolytic administration has been demonstrated (3) in 46% of patients treated with the best of the current thrombolytic regimens. Because clinical assessment of thrombolytic efficacy is unreliable (4, 5) , a rapid noninvasive method of detecting failure of complete reperfusion of the IRA could be of considerable assistance, by identifying the patients who might benefit from further reperfusion strategies, such as rescue angioplasty (6) .
Because the kinetics of release and clearance of the conventional biochemical markers of myocardial necrosis are not sufficiently sensitive to monitor reperfusion within the first 60 to 90 min noninvasively, attempts have been made to improve their sensitivity and specificity by means of multiple samples and the construction of time-activity curves (7) (8) (9) (10) (11) (12) (13) (14) (15) . These methods are complex and time consuming. The use of newer serum markers of myocyte necrosis, such as myoglobin (16) and cardiac troponin T (17), could simplify the task. Levels of these proteins rise rapidly in the serum after successful reperfusion therapy of MI (18 -22) . An analysis based on their early and rapid rate of release into the bloodstream if TIMI grade 3 flow is restored to the IRA may allow noninvasive assessment of thrombolytic efficacy.
The present study sought to assess the value of myoglobin, cardiac troponin T and creatine kinase-MB fraction concentration (CKMB mass) as predictors of failure of early restoration of TIMI grade 3 flow in acute MI.
Methods
Patients. The patients involved were enrolled in two reperfusion studies that have been described elsewhere (23, 24) . Patients who presented with typical ischemic chest pain Ͼ20 min in duration and Ն1-mm ST segment elevation in two contiguous electrocardiographic (ECG) leads, were treated with aspirin (300 to 325 mg) and 1.5 million U of streptokinase by rapid infusion (over 30 to 60 min), followed by either heparin or hirulog (as a bolus plus infusion).
Patients were considered current smokers if they smoked tobacco regularly or had stopped smoking within the previous 6 months and were considered hypertensive if they were receiving antihypertensive medication at admission. Dyslipidemia was defined as a fasting total serum cholesterol Ն5.2 mmol/liter. Diabetic patients were those requiring treatment, with or without insulin, for carbohydrate intolerance.
Biochemical markers. Blood samples for myocardial protein measurement were drawn immediately before starting the streptokinase infusion and at 30, 60, 90 and 120 min after the start of thrombolytic therapy. The status of the IRA was assessed at 90 min by coronary arteriography, and coronary flow was graded according to TIMI criteria (1) by consensus between an experienced cardiologist and cardiac radiologist who had no knowledge of the clinical state of the patient and the results of the biochemical markers. Any disagreement was resolved by consensus with a third observer. Angiographic analyses were performed at two separate sites, both of which are experienced angiographic core laboratories for multicenter trials. Direct correlation of TIMI flow readings between the two sites was not performed because most of the reported variation between observers applies to TIMI grade 2 flow rather than TIMI grade 3 flow (25) .
To determine whether cardiac catheterization could contribute to an increase in the serum levels of the markers used, particularly of myoglobin, a group of 19 patients undergoing elective coronary angioplasty for nonoccluded vessels during the same time period as the reperfusion studies were investigated. No significant changes in the serum levels of any of the markers occurred after arterial puncture and routine coronary angioplasty (sampling performed at 30, 60 and 120 min after arterial puncture).
Biochemical analysis. CKMB concentration (CKMB mass) was assayed by the Stratus II immunoassay (Baxter); myoglobin was measured with either the Behring immunologic technique on an Opus analyzer (PB Diagnostics) or the Baxter Stratus II immunoassay. Cardiac troponin T was measured by an enzyme-linked immunoassay using Boehringer Mannheim reagents (Mannheim, Germany) on a Boehringer ES 300 analyzer. The normal values for these proteins in our laboratories are CKMB mass Յ5 ng/ml; troponin T Յ0.1 ng/ml; myoglobin Յ110 ng/ml.
Data analysis.
Results are expressed as mean value Ϯ SD where appropriate or as median (interquartile range) for data not normally distributed. The concentrations of the marker proteins obtained after the administration of streptokinase were converted to ratios by dividing by the pretreatment value. The 60-and 90-min ratios were examined for their ability to discriminate between patients with TIMI grade 3 flow and those with lower TIMI flow grades in the IRA at the 90-min angiogram. Receiver operator characteristic (ROC) curves were constructed for the sensitivities and specificities of the ratios for the detection of TIMI grade 0 to 2 flow at 60 and 90 min (Fig. 1) for ratios between 1.0 (i.e., no rise in concentration of marker protein vs. baseline levels) and the ratio at which the curve became asymptotic (i.e., no further increase in sensitivity). The predictive values (positive and negative) were calculated for two ratios from the section of the ROC curve with the best balance between sensitivity and specificity. The same ratios were chosen for all three marker proteins because their ROC curves were similar.
Statistical analyses were performed using SPSS for Windows Version 6.1 running on a personal computer. Betweengroup analyses were made using a Kruskall-Wallis H test (for data not normally distributed) and where there was a statistically significant result (p Ͻ 0.05), post hoc comparisons between individual groups were made using a Mann-Whitney U test corrected for multiple comparisons by multiplying the p value obtained by the number of comparisons made. This is a rigorous and conservative method of correcting for multiple comparisons in nonparametric analyses. Within-group comparisons for nonparametric data were made using a Friedman two-way analysis of variance, and matched-pairs comparisons were made using a Wilcoxon matched-pairs signed-rank test, again corrected for multiple comparisons by multiplying the p value obtained by the number of comparisons made. Nominal data were evaluated using a chi-square test.
Results
Patients. The study included 105 patients (78% male; mean age 59.1 Ϯ 10.4 years); their background characteristics are summarized in Table 1 . Treatment with intravenous streptokinase was instituted within 4 h of the onset of chest pain in 73% of patients and within 3 h in 55%. TIMI grade 3 flow in the IRA was seen in 59 patients (56%) at 90 min. Of the remaining 46 patients, 20 had TIMI grade 0, 6 had TIMI grade 1, and 20 had TIMI grade 2 flow. TIMI grade 3 flow was seen more often in current smokers than nonsmokers (p Ͻ 0.05) and in patients presenting with their first myocardial infarction (p Ͻ 0.05). However, patients with TIMI grade 3 flow were not significantly different from the other patients with respect to other major risk factors for coronary disease (history of hypertension, dyslipidemia or diabetes). Sixty-eight percent of patients with TIMI grade 3 flow presented within 3 h of symptom onset, whereas only 40% of patients with lower flow grades presented within 3 h (p Ͻ 0.01). On multivariate logistic regression analysis of all the baseline variables, only time to treatment (p ϭ 0.003) and gender (p ϭ 0.05) were independent predictors of TIMI grade 3 flow in the IRA at 90 min.
The serum levels of the marker proteins measured before streptokinase infusion were within the normal range for our laboratories in most patients (CK activity 78%, CKMB mass 80%, troponin T 83%), apart from myoglobin concentration, which was in the normal range in only 50%. For the 58 patients (55%) who received streptokinase within 3 h of symptom onset, serum levels were within the normal range for CK activity in 91%, troponin T in 96%, CKMB mass in 95% and myoglobin in 75%.
Serum levels of the myocardial proteins between 0 and 120 min after streptokinase administration are presented (median [25th, 75th percentiles]) in Table 2 . The ratios of these proteins at 30, 60, 90 and 120 min after the start of the streptokinase infusion to the pretreatment values are shown in Figure 2 .
Results by TIMI flow grade. At 30 min there was minimal elevation of CKMB mass and myoglobin concentrations in patients with TIMI grade 3 flow in the IRA but no change in troponin T. The concentrations of all three markers were significantly raised by 60 and 90 min ( Table 2, Fig. 2 ). The median CKMB mass ratios at 60 and 90 min, respectively, were 5.6 and 10.0; those for troponin T were 3.0 and 14.7, respectively, and those for myoglobin were 7.7 and 19.3, respectively (p Ͻ 0.001 at 60 min and p Ͻ 0.0001 at 90 min vs. baseline). As shown in Table 2 and Figure 2 , CKMB mass and troponin T levels were still rising rapidly 120 min after thrombolytic therapy, but myoglobin levels were not significantly different from those at 90 min.
In the patients with TIMI grade 0 to 2 flow at 90 min, the myoglobin and CKMB mass ratios were 2.0 and 1.8, respectively, at 60 min (both p Ͻ 0.002). The rise in troponin T concentrations was less (median ratio 1.0, p Ͻ 0.01). The ratios of all three markers were raised at 90 min (p Ͻ 0.0001 vs. baseline), but the magnitude of the change was less in patients with TIMI grade 0 to 2 flow than in patients with TIMI grade 3 flow: CKMB mass ratio 2.9, troponin T ratio 2.5 myoglobin ratio 2.2. At 120 min, the ratios were CKMB mass 3.3 (p ϭ 0.003), troponin T 4.0 (p Ͻ 0.001) and myoglobin 2.9 (p Ͻ 0.001) compared with 90 min.
Diagnosis of reperfusion. At 60 min after the start of streptokinase infusion, the median marker ratios for patients with TIMI grade 3 and TIMI grade 0 to 2 flow in the IRA were, respectively, CKMB mass 5.6 and 2.0 (p ϭ 0.002); troponin T 3.0 and 1.0 (p Ͻ 0.005); and myoglobin 7.8 and 1.8 (p ϭ Data presented are mean value Ϯ SD, median (25th, 75th percentiles) or number (%) of patients. Ant ϭ anterior; CK peak ϭ peak value of creatine kinase activity; HTN ϭ hypertension; Nonant ϭ nonanterior; Prev MI ϭ previous myocardial infarction; Time to SK ϭ time from onset of chest pain to start of streptokinase infsuion; TIMI ϭ Thrombolysis in Myocardial Infarction. 0.0003). The median 90-min marker ratios for patients with TIMI grade 3 and TIMI grade 0 to 2 flow in the IRA were, respectively, CKMB mass 10.0 and 2.9; troponin T 14.7 and 2.5; and myoglobin 19.3 and 2.2. These differences were all statistically significant (p Ͻ 0.0001). The power of these ratios to discriminate between patients with TIMI grade 3 flow and those with TIMI grade 0 to 2 flow, by the Mann-Whitney U test, was high for all three markers (CKMB mass 0.9, troponin T 0.7, myoglobin 0.9) regardless of the assumptions about the distribution of values. There were no significant differences in the ratios at 60 or 90 min between patients with TIMI grade 0 or 1 flow and those with TIMI grade 2 flow in the IRA at 90 min.
To determine the sensitivity and specificity of individual markers for detecting TIMI flow grades Ͻ3 at 60 and 90 min after commencing streptokinase infusion, ROC curves were constructed (Fig. 1) . The sensitivities, specificities and positive and negative predictive values for ratios of 1.5 and 5 at 60 min and for ratios of 5 and 10 at 90 min are shown in Table 3 . The use of a ratio of 5 at 60 min and and a ratio of 10 at 90 min for any of the three proteins was sensitive for the detection of TIMI flow grades Ͻ3, with the best negative predictive value (94%) at both times provided by troponin T. These ratios correspond to the section of the ROC curves showing the best balance between sensitivity and specificity. The use of higher ratios to triage patients for invasive investigation or other therapies would therefore add little sensitivity and would reduce the specificity, as illustrated in Figure 1 .
To determine whether baseline differences, such as time to treatment, between patients with TIMI grade 3 flow and those with TIMI grade 0 to 2 flow might affect the ability of the ratios at 60 and 90 min for predicting TIMI grade 0 to 2 flow, the sensitivities of the ratios were assessed independently for early (Յ3 h) versus late (Ͼ3 h) treatment, smoking habits, previous myocardial infarction and gender. When all subgroups were examined, the sensitivities for 60-min marker ratios of 5 for detecting 90-min TIMI grade 0 to 2 flow ranged from 80% to 100% and those for 90-min ratios of 10 between 83% and 100%.
Discussion
Noninvasive prediction of failed reperfusion. In the prethrombolytic era it was shown (26) that levels of biochemical markers of myocardial necrosis in peripheral blood remained essentially normal for several hours after acute myocardial infarction. In the present study, the levels of myocardial proteins (CKMB mass, troponin T and myoglobin) were within the normal range in most patients at the time of presentation. The changes in serum concentration of these proteins after intravenous streptokinase were examined as a noninvasive indicator of failure to achieve TIMI grade 3 flow in the IRA.
The ideal noninvasive assessment of thrombolytic efficacy would allow sufficient time for reperfusion to take place while providing evidence of failure of reperfusion quickly enough for other strategies to be used. We prospectively collected samples at 30 min after the start of thrombolytic therapy to develop noninvasive criteria for determining reperfusion, but assessment at ϳ60 min is probably the earliest practical time to evaluate incomplete reperfusion noninvasively. In the present study, if the cardiac troponin T ratio was Յ5 at 60 min, then failure of treatment to restore 90-min TIMI grade 3 flow was identified with 97% sensitivity and 43% specificity. If the ratio was Յ10 at 90 min, then TIMI flow grades Ͻ3 were predicted with 95% sensitivity and 58% specificity. The negative predictive value was high in both cases (94%); thus, if the troponin T ratio 60 min after the start of thrombolysis was Ͼ5 or Ͼ10 after 90 min, it was 94% certain that there was TIMI grade 3 flow in the IRA. Nevertheless, both myoglobin and CKMB mass ratios appeared to have a sensitivity and specificity for the detection of TIMI grade 0 to 2 flow similar to that of the troponin T ratio (Table 3) . A CKMB mass ratio of 10 at 90 min had a negative predictive value of 87%, whereas a 90-min myoglobin ratio of 10 had a negative predictive value of 86%. As shown in Table  3 , the sensitivities, specificities and positive and negative predictive values at 60 min were similar to those at 90 min for all three markers.
Implications for the triage of patients with myocardial infarction. Myoglobin is probably the most sensitive available marker of myocardial necrosis and may be the biochemical marker of choice for the early diagnosis of myocardial infarction. It is released into the circulation early after myocyte damage (16, 18, 20) but lacks tissue specificity (19) . There is rapid renal clearance of myoglobin (in the absence of renal failure or low cardiac output) (27) , which may limit its usefulness, especially in patients who present late. However, cardiac CKMB ϭ creatine kinase, MB fraction; NPV ϭ negative predictive value; PPV ϭ positive predictive value; Sens ϭ sensitivity; Spec ϭ specificity. troponin T is highly specific for myocardium and demonstrates a pattern of early but sustained release after myocyte damage (28) . Although troponin T has greater tissue specificity than the other markers studied, our results imply that a system of triage for patients with MI treated with intravenous thrombolytic therapy could be based on any one of the three.
If a triage system were based on a 60-min marker ratio Յ5 to identify patients likely to have 90-min TIMI grade flow Ͻ3 in the IRA, it would identify nearly all patients with "failure of reperfusion." Because all three proteins can now be analyzed with a laboratory turnaround time of Ͻ15 min, any one of the three could be useful for the identification of patients who might benefit from other procedures, such as cardiac catheterization with a view to rescue coronary angioplasty. If this strategy were adopted, the positive predictive value of 63% to 76% for a ratio of 5 means that a small proportion of patients would have TIMI grade 3 flow in the IRA at 90 min, and may undergo catheterization unnecessarily.
Incomplete reperfusion. Patients who have TIMI grade 2 flow in the IRA after thrombolysis have a poorer outcome than those with TIMI grade 3 flow (2,29), although it is not yet clear whether TIMI grade 2 flow is the cause of a poorer outcome or merely a marker of increased risk for adverse events (30) . The Second Thrombolytic Trial of Eminase (Anistreplase) in Acute Myocardial Infarction (TEAM-2) (31) and third TEAM (TEAM-3) (32) studies also showed a difference in the kinetics of the biochemical markers of myocardial infarction, with more rapid enzyme release and smaller enzyme peaks (probably indicating less myocardial necrosis) in patients with TIMI grade 3 flow than in those with TIMI grade 2 flow. Analysis of the 20 patients in the present series with TIMI grade 2 flow supports the concept that TIMI grade 2 flow represents a "mostly occluded artery" because in these 20 patients the CKMB mass ratio at 90 min was Ͻ10 in 85%, the troponin T ratio was Ͻ10 in 89%, and the myoglobin ratio was Ͻ10 in 81%.
Comparison with other studies. Our data are consistent both with the earlier reperfusion studies using time-activity curves of traditional markers (7) (8) (9) (10) (11) (12) (13) (14) (15) and with newer studies based on the release patterns of myoglobin and cardiac troponin T. Zabel et al. (20) concluded that the slope of the change in serum marker concentration within the first 90 min after thrombolysis was a sensitive and specific measurement of thrombolytic success and that myoglobin was the most useful marker because of its early rise. They did not find troponin T analysis to be any more useful than analysis of CK or CKMB activity. However, in a small Japanese study (33) , a significant increase in troponin T level was seen 60 min after reperfusion with either intracoronary thrombolysis or angioplasty. We also found that the troponin T ratio had begun to rise abruptly by 60 min, although the changes were more definite by 90 min. The Prospective Evaluation of Reperfusion Markers (PERM) group (34) found that the relative increase in marker levels, particularly for myoglobin, troponin T and CK-MM3/CK-MM1 isoforms, as a better predictor of IRA patency than were the slopes of the changes. Those investigators found (34) that the relative increase of any one of their three markers above a certain threshold could be used as a noninvasive diagnostic test for patency of the IRA, but they judged that of the three, myoglobin was probably the marker of choice.
Limitations of the study. The TIMI flow and the marker concentration data reported here are from two different institutions and were not directly compared. Each patient acted as his or her own control in the calculation of the marker ratios, so this approach is not likely to have introduced an error at that level. Threshold marker ratios to determine TIMI grade 0 to 2 flow, especially at 60 min, may be further defined by construction of ROC curves from a larger study sample.
There may have been a discrepancy between the two angiographic core laboratories with respect to TIMI flow grading. The TIMI flow classification has proved useful both in research and in clinical practice but is a subjective index, and considerable interobserver variation in flow grading between local and core laboratory assessment has been shown (25) . This variation is seen most often with TIMI grade 2 flow and rarely with TIMI grade 3 flow, so we consider any error introduced in this way to be small.
Conclusions. The present study showed that after thrombolytic therapy for acute myocardial infarction, the ratios of the serum levels of myocardial proteins at 60 and 90 min to prethrombolytic values can be used to predict which patients will not have TIMI grade 3 flow in the IRA at 90 min. The method allows simple, rapid and reliable diagnosis of TIMI flow grades Ͻ3 with no need for the construction of complex time-activity curves for the various marker proteins or correction for the concentration of the marker at the time of presentation. The index appears to be independent of the site and extent of infarction, the duration of symptoms before the start of thrombolytic therapy, the gender of the patient and the history of previous infarction. Although the present study was performed with the "traditional" laboratory-based assays, all three proteins can now be assayed rapidly (within 15 min), allowing an answer to be obtained quickly at the bedside (33, 35) . Our results also provide the basis for a prospective study to determine whether patients with apparent failure of reperfusion after intravenous thrombolytic therapy, based on noninvasive testing, would benefit from other therapies.
